Remibrutinib (LOU064) in Sjogren's Syndrome: Safety and Efficacy Results from a 24-Week Placebo-controlled Proof-of-Concept StudyThomas Dorner,Antonia Szanto,Jui-Cheng Tseng,Martin Kaul, Ilona Pylvaenaeinen, Malika Hanser,Nasri Abdallah,Bruno Cenni,Richard SiegelARTHRITIS & RHEUMATOLOGY(2022)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要